gms | German Medical Science

64. Jahrestagung der Deutschen Gesellschaft für Medizinische Informatik, Biometrie und Epidemiologie e. V. (GMDS)

Deutsche Gesellschaft für Medizinische Informatik, Biometrie und Epidemiologie

08. - 11.09.2019, Dortmund

Blinded Sample Size Recalculation in Adaptive Enrichment Designs

Meeting Abstract

Suche in Medline nach

  • Marius Placzek - Universitätsmedizin Göttingen, Göttingen, Germany
  • Tim Friede - Universitätsmedizin Göttingen, Göttingen, Germany

Deutsche Gesellschaft für Medizinische Informatik, Biometrie und Epidemiologie. 64. Jahrestagung der Deutschen Gesellschaft für Medizinische Informatik, Biometrie und Epidemiologie e.V. (GMDS). Dortmund, 08.-11.09.2019. Düsseldorf: German Medical Science GMS Publishing House; 2019. DocAbstr. 286

doi: 10.3205/19gmds005, urn:nbn:de:0183-19gmds0058

Veröffentlicht: 6. September 2019

© 2019 Placzek et al.
Dieser Artikel ist ein Open-Access-Artikel und steht unter den Lizenzbedingungen der Creative Commons Attribution 4.0 License (Namensnennung). Lizenz-Angaben siehe http://creativecommons.org/licenses/by/4.0/.


Gliederung

Text

With growing interest in personalized medicine and targeted therapies the focus on adaptive trial designs for subgroup analyses is increasing as well. Here we take a look at a combination of a blinded sample size recalculation procedure in an internal pilot study and subgroup selection at interim analyses [1], [2]. The increasing complexity of such an adaptive enrichment design with sample size review comes with an increasing number of nuisance parameters that have to be estimated or reestimated, e.g. prevalences of the subgroups, variances in the subgroups, timepoint of the sample size review and timepoint of the interim analysis. Additionally, for the final analysis the different stages of the design have to be combined while still controlling the familywise error rate. Accounting for this we will present two adaptive testing strategies, the combination test [3] and the conditional error function approach [4]. For nested as well as non-overlapping subgroups with normally distributed endpoints we explore the effect of estimating the variances in the subpopulations and the varying timepoints of the sample size review and interim analysis. We give exact results using a multivariate t-distribution where possible and provide approximations otherwise. The performance of the proposed methods are analysed via simulations.

The authors declare that they have no competing interests.

The authors declare that an ethics committee vote is not required.


References

1.
Placzek M, Friede T. Clinical trials with nested subgroups: Analysis, sample size determination and internal pilot studies. Statistical Methods in Medical Research. 2017;27(11):3286-3303.
2.
Placzek M, Friede T. A conditional error function approach for adaptive enrichment designs with continuous endpoints. Statistics in Medicine. 2019;38(17):3105-3122.
3.
Brannath W, Zuber E, Branson M, Bretz F, Gallo P, Posch M, et al. Confirmatory adaptive designs with Bayesian decision tools for a targeted therapy in oncology. Statistics in Medicine. 2009;28(10):1445-1463.
4.
Friede T, Parsons N, Stallard N. A conditional error function approach for subgroup selection in adaptive clinical trials. Statistics in Medicine. 2012;31(30):4309-4320.